Recall Z-3134-2026

Nipro Renal Soultions USA, Corporation · initiated August 5, 2026

Class II Open, Classified

Class II – products that might cause a temporary health problem or pose a slight threat of a serious nature

Product

MedicaLyte Bicarbonate Powder REF: DB+201-2.1(45X) and DB+201-25 (35X, 36.83X, 45X))

Codes / lots: DB+201-2.1: Lot -NDB5E004(exp.4/30/2027) DB+201-25: Lots - NDB5M011(Exp.12/05/2027, NDB4J003(exp.9/25/2026)

Reason for recall

Hemodialysis concentrates contain high endotoxin levels

FDA-determined cause: Process control

Action taken

On August 6, 2026 Nipro Medical Corporation issued a Urgent Medical Device Recall notification via Email. Nipro asked consignees to take the following actions: 1. Immediately examine your inventory for the affected product codes and lot numbers listed on the Recall response form. 2. Immediately segregate, quarantine, and discontinue use or distribution of any affected product in your possession. 3. Do not use, sell, transfer, or distribute affected products. 4. Complete the enclosed Recall Response Form within 10 business days, even if you do not have affected product on hand. 5. Contact Nipro customer service for product return and credit, if applicable. 6. If you distributed affected product, promptly notify your customers, provide them with a copy of this recall notice, and request that they complete and return the response form or equivalent confirmation. 7. Product Return or Disposition: Affected products should remain quarantined until return, destruction, or other documented disposition instructions are provided by Nipro. Please retain all documentation related to product quarantine, return, destruction, or other disposition for recall reconciliation.

Details

Recall number
Z-3134-2026
Initiated
August 5, 2026
Posted by FDA
September 10, 2026
Product code
KPO – Dialysate Concentrate For Hemodialysis (Liquid Or Powder)
Quantity
2,327 cases
Distribution
Worldwide - US Nationwide distribution in the states of FL, GA, IL, MD, MI, NC, NJ, NV, OH, PA, and the countries of Guatemala and Panama.
Recalling firm
Nipro Renal Soultions USA, Corporation, Lewisberry, PA

Official FDA recall record

Other products in the same recall event

RecallProductInitiated
Z-3133-2026 Class IIMedicaLyte Liquid Bicarbonate Concentrate REF: BC-100 and BC+201Hemodialysis concentrates contain high endotoxin levels 08/05/2026Open, Classified
Z-3135-2026 Class IICitric Complete Dry Citric Acid Concentrate REF: DCA+200-25 & DCA+203-25Hemodialysis concentrates contain high endotoxin levels 08/05/2026Open, Classified
Z-3136-2026 Class IICitric Complete Liquid Citric Acid Concentrate REF: LC+200-D,LC+201, LC+225(45X)Hemodialysis concentrates contain high endotoxin levels 08/05/2026Open, Classified